Nisha Nanda
Direttore/Membro del Consiglio presso MORPHIC HOLDING, INC.
Patrimonio netto: - $ in data 30/06/2024
Profilo
Nisha Nanda is an Independent Director at Morphic Holding, Inc. She previously worked as a Senior Director-Clinical Science at Onyx Pharmaceuticals, Inc. from 2012 to 2014.
She then served as the Chief Development Officer at Loxo Oncology, Inc. from 2019 to 2023.
Dr. Nanda holds undergraduate and doctorate degrees from The University of New South Wales.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
MORPHIC HOLDING, INC.
-.--% | 04/06/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Posizioni attive di Nisha Nanda
| Società | Posizione | Inizio |
|---|---|---|
| MORPHIC HOLDING, INC. | Direttore/Membro del Consiglio | 19/08/2021 |
Precedenti posizioni note di Nisha Nanda
| Società | Posizione | Fine |
|---|---|---|
| LOXO ONCOLOGY INC | Corporate Officer/Principal | 01/05/2023 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/02/2014 |
Formazione di Nisha Nanda
| The University of New South Wales | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Borsa valori
- Insiders
- Nisha Nanda
